LatAm investigators prefer pharma, not CRO, run trials
Latin American investigators prefer pharma companies, as opposed to CROs, to handle day-to-day clinical trials operations, according to a survey.
Latin American investigators prefer pharma companies, as opposed to CROs, to handle day-to-day clinical trials operations, according to a survey.
Russian authorities need to dedicate more resources to reviewing trial applications ahead of new site accreditation rules due to come into effect later this year according to report on the country’s contract research sector.
A study shows mAbs processed with fast acting dehydration show equivalent structural changes to freeze dried compounds after a year, EnWave claims.
Encap Drug Delivery now offers a ‘feasibility package’ to assess the potential of its Phoral coating technology as a vehicle for therapy in colonic diseases.
Intersect have received the FDA seal of approval of their targeted drug delivery technology for treatment in chronic sinusitis patients.